Journal of Enzyme inhibition and Medicinal Chemistry

Journal of Enzyme inhibition and Medicinal Chemistry

J ENZYM INHIB MED CH

5.6 (2023)
1475-6366
Yes
Informa Healthcare
Bimonthly
EUR2520; USD2630; GBP2100
2002
195
8.9%
Major category Minor category TOP journal Review journal
Q2

MEDICAL

BIOCHEMISTRY AND MOLECULAR BIOLOGY No No

BIOCHEMISTRY & MOLECULAR BIOLOGY

CiteScore SJR SNIP CiteScore ranking
10.3 0.949 1.223
Subject Area Rank Percentile
Pharmacology, Toxicology and PharmaceuticsPharmacology 31 / 313 90%
61
Science Citation Index Expanded
21 days avg. from submission to first decision 30 days avg. from submission to first post-review decision 11 days avg. from acceptance to online publication
Journal of Enzyme Inhibition and Medicinal Chemistry publishes open access research on enzyme inhibitors, inhibitory processes, and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents.

Journal of Enzyme Inhibition and Medicinal Chemistry aims to provide an international and interdisciplinary platform for the latest findings in enzyme inhibition research.

The journal’s focus includes current developments in:

Enzymology
Cell biology
Chemical biology
Microbiology
Physiology
Pharmacology leading to drug design
Molecular recognition processes
Distribution and metabolism of biologically active compounds


Across these fields of study, special attention is given to:

Structure and molecular aspects
Enzyme kinetics and inactivation mechanisms
Structure-activity relationships (QSAR, graphic techniques)
Drug development studies and drug release
Control mechanisms in metabolic processes


Journal of Enzyme Inhibition and Medicinal Chemistry accepts original articles, reviews/systematic reviews, methods, brief reports, data notes, discussions, editorials and letters to the editor.
Disclaimer:
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.